Bifidobacterium animalis subsp. lactis BS01™ (LMG P-21384)

Allergy & Immunology
Immune Support
Supports balanced, healthy immune responses [in vitro]
Single strain
Blend
Finished dosage form
a) Mogna L. et al. Micronized Cells of the Probiotic Strain Bifidobacterium lactis BS01 Activate Monocyte Polarization: A New Approach. J Clin Gastroenterol. 2018;52:S57-S61.doi: 10.1097/MCG.0000000000001068
b) Visciglia A. et al. Probiotics: a potential therapeutic strategy in respiratory infections. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Microbiota Health, held in Rome on 12-14 September 2021
Internal data on immune stimulation available upon request
For information on blends containing BS01™, see the following Blends and Products pages:
- BIFIVIR®
- BIFIMMUN®
- BIFIFIBER®
- GG+ BS01™ + BR03™ + BL03
- BS01™ + LR05 / PROBIAL® Skin Atopic
- PROBIAL® BONE
- PROBIAL® Vision Dry
Gastroenterology
BOWEL TRANSIT/OCCASIONAL CONSTIPATION
Reduces occasional constipation
Supports healthy intestinal transit time
1) 3) 5 billion CFU
2) 10 billion CFU
Single strain
Blend
Finished dosage form
1) Del Piano M. et al. The use of probiotics in healthy volunteers with evacuation disorders and hard stools. A double blind, randomized, placebo controlled study. J Clin Gastroenterol, 2010; 44(8):S30-34. doi:10.1097/MCG.0b013e3181ee31c3
2) Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly. CIBUS, 2005; 1(1):23-30.
3) Dimidi E. et al. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2014;100:1075–84. doi: 10.3945/ajcn.114.089151
For information on blends containing BS01™, see the Blends and Products pages listed above.
Neurology
Neuro-immune Health
Supports healthy immune and antioxidant responses in blood cells [in vitro]
Single strain
Blend
Finished dosage form
a) Magistrelli L. et al. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Front Immunol. 2019 May 7;10:969. doi: 10.3389/fimmu.2019.00969
For information on blends containing BS01™, see the Blends and Products pages listed above.